306 related articles for article (PubMed ID: 18294022)
1. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
Avery DH; Isenberg KE; Sampson SM; Janicak PG; Lisanby SH; Maixner DF; Loo C; Thase ME; Demitrack MA; George MS
J Clin Psychiatry; 2008 Mar; 69(3):441-51. PubMed ID: 18294022
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
O'Reardon JP; Solvason HB; Janicak PG; Sampson S; Isenberg KE; Nahas Z; McDonald WM; Avery D; Fitzgerald PB; Loo C; Demitrack MA; George MS; Sackeim HA
Biol Psychiatry; 2007 Dec; 62(11):1208-16. PubMed ID: 17573044
[TBL] [Abstract][Full Text] [Related]
3. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.
Lisanby SH; Husain MM; Rosenquist PB; Maixner D; Gutierrez R; Krystal A; Gilmer W; Marangell LB; Aaronson S; Daskalakis ZJ; Canterbury R; Richelson E; Sackeim HA; George MS
Neuropsychopharmacology; 2009 Jan; 34(2):522-34. PubMed ID: 18704101
[TBL] [Abstract][Full Text] [Related]
4. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
5. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
[TBL] [Abstract][Full Text] [Related]
7. A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients.
George MS; Raman R; Benedek DM; Pelic CG; Grammer GG; Stokes KT; Schmidt M; Spiegel C; Dealmeida N; Beaver KL; Borckardt JJ; Sun X; Jain S; Stein MB
Brain Stimul; 2014; 7(3):421-31. PubMed ID: 24731434
[TBL] [Abstract][Full Text] [Related]
8. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment.
Janicak PG; O'Reardon JP; Sampson SM; Husain MM; Lisanby SH; Rado JT; Heart KL; Demitrack MA
J Clin Psychiatry; 2008 Feb; 69(2):222-32. PubMed ID: 18232722
[TBL] [Abstract][Full Text] [Related]
9. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder.
Kim DR; Wang E; McGeehan B; Snell J; Ewing G; Iannelli C; O'Reardon JP; Sammel MD; Epperson CN
Brain Stimul; 2019; 12(1):96-102. PubMed ID: 30249416
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Active vs Sham Intermittent Theta Burst Transcranial Magnetic Stimulation for Patients With Bipolar Depression: A Randomized Clinical Trial.
McGirr A; Vila-Rodriguez F; Cole J; Torres IJ; Arumugham SS; Keramatian K; Saraf G; Lam RW; Chakrabarty T; Yatham LN
JAMA Netw Open; 2021 Mar; 4(3):e210963. PubMed ID: 33710288
[TBL] [Abstract][Full Text] [Related]
12. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
[TBL] [Abstract][Full Text] [Related]
13. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
[TBL] [Abstract][Full Text] [Related]
14. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
[TBL] [Abstract][Full Text] [Related]
16. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
17. Cognitive outcomes of transcranial magnetic stimulation in treatment-resistant depression: a randomized controlled study.
Yıldız T; Oğuzhanoğlu NK; Topak OZ
Turk J Med Sci; 2023 Feb; 53(1):253-263. PubMed ID: 36945926
[TBL] [Abstract][Full Text] [Related]
18. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
Janicak PG; Nahas Z; Lisanby SH; Solvason HB; Sampson SM; McDonald WM; Marangell LB; Rosenquist P; McCall WV; Kimball J; O'Reardon JP; Loo C; Husain MH; Krystal A; Gilmer W; Dowd SM; Demitrack MA; Schatzberg AF
Brain Stimul; 2010 Oct; 3(4):187-99. PubMed ID: 20965447
[TBL] [Abstract][Full Text] [Related]
19. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
[TBL] [Abstract][Full Text] [Related]
20. Transcranial magnetic stimulation (TMS) in the treatment of attention-deficit/hyperactivity disorder in adolescents and young adults: a pilot study.
Weaver L; Rostain AL; Mace W; Akhtar U; Moss E; O'Reardon JP
J ECT; 2012 Jun; 28(2):98-103. PubMed ID: 22551775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
